With the widespread increase in elderly populations, the quality of life and mental health in
old age are issues of great interest. The human brain changes with age, and the brain aging …

Background: While longitudinal studies have investigated the relationships between mild
cognitive impairment (MCI) subtypes and dementia subtypes, the results have been …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread
rapidly since 2019, and the number of reports regarding long COVID has increased. Although …

Aim Live two‐way video, easily accessible from home via smartphones and other devices,
is becoming a new way of providing psychiatric treatment. However, lack of evidence for real‐…

Background Plasma biomarkers have emerged as promising screening tools for Alzheimer’s
disease (AD) because of their potential to detect amyloid β (Aβ) accumulation in the brain. …

Background and Objectives Previous studies have evaluated the diagnostic effect of amyloid
PET in selected research cohorts. However, these studies did not assess the clinical impact …

Introduction Psychiatric disorders are diagnosed through observations of psychiatrists
according to diagnostic criteria such as the DSM-5. Such observations, however, are mainly …

A number of studies have examined the effect of a single supplement against Alzheimer's
disease (AD) with conflicting results. Taking into account the complex and multifactorial nature …

Introduction Depressive and neurocognitive disorders are debilitating conditions that account
for the leading causes of years lived with disability worldwide. However, there are no …

Rationale & Objective Chronic kidney disease, defined by albuminuria and/or reduced estimated
glomerular filtration rate (eGFR), has been reported to be associated with brain atrophy …